v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net loss $ (6,664,371) $ (4,842,142)
Adjustments to reconcile net loss to cash used in operating activities:    
Stock compensation expense 1,424,736 334,604
Depreciation and amortization 14,058 34,307
Amortization of debt discount   17,383
Change in fair value of derivative liability   (12,092)
Changes in operating assets and liabilities    
Other current assets (29,998) (1,408)
Other noncurrent assets 71,612 (56,777)
Accounts payable and accrued expenses 445,541 691,880
Net cash flows from operating activities (4,738,422) (3,834,245)
Cash flows from investing activities:    
Deposits and advances, planned business acquisition (1,108,375)  
Purchase of property and equipment (42,672)  
Net cash flows from investing activities (1,151,047)  
Cash flows from financing activities:    
Cash dividend payment of preferred stock Series A (2,089)  
Proceeds from warrants exercised 504,211  
Proceeds from convertible notes payable   4,903,000
Payment of debt issuance costs   (272,297)
Payment of transaction costs related to Kintara merger (500,000)  
Payment of net liabilities assumed in reverse recapitalization with Kintara (550,000)  
Net cash flows from financing activities (547,878) 4,630,703
Net change in cash and cash equivalents (6,437,347) 796,458
Cash and cash equivalents at the beginning of the period 12,657,178 3,665,032
Cash and cash equivalents at the end of the period 6,219,831 4,461,490
Supplemental non-cash activity    
Due from stockholders not yet received for warrant exercises 3,057,904  
Right-of-use asset recognized in exchange for operating lease obligations   318,722
Debt issuance costs not yet paid   379,063
Deferred offering costs not yet paid $ 13,965 284,867
Derivative liability associated with make-whole premium   $ 228,092

Source

HTML PDF
ZIP